• Blog
  • Nootropics Market Growth & Forecast Analysis | 2022-2028

    Nootropics Market Growth & Forecast Analysis | 2022-2028

    Nootropics Market Growth & Forecast Analysis | 2022-2028
    Report code - SRHL255 Delivery - 2 Weeks
    Nootropics Market Size, Share, Trends, Dynamics, Growth, & Forecast Analysis- 2022-202 See more...

    Market Insights

    The nootropics market was estimated at USD 10.7 billion in 2021 and is likely to grow at a CAGR of 15.07% during 2022-2028 to reach USD 28.66 billion in 2028.


    To learn more about this report, Request a Sample Here.

    What are Nootropics?

    Nootropics are drugs or supplements that are consumed by sportsmen and adults to enhance memory and other cognitive abilities. These are available in both OTC form and prescription drug type, wherein prescription nootropics are drugs that are used to treat diseases such as ‘attention deficit hyperactivity disorder’ (ADHD), Alzheimer’s disease, and narcolepsy. Whereas non-prescription drugs or OTC do not treat diseases but are consumed for improving brain performance and concentration capabilities.


    The COVID-19 pandemic has positively influenced the nootropics industry. Concern over COVID-19, unemployment, and poor economic growth has resulted in a rise in the consumer’s stress levels which puts a strain on overall brain health. Thus, there has been a significant demand for nootropics that boost the mood and help to manage stress during this hard time, thus augmenting the market growth.

    Nootropics Market Highlights

    Market Size in 2021

    USD 10.7 billion

    Market Size in 2028

    USD 28.66 billion

    Market Growth (2022-2028)

    15.07% CAGR

    Base Year of Study


    Trend Period


    Forecast Period


    Market Dynamics

    Increasing demand for smart drugs and brain boosters is likely to augment the demand for nootropics.

    • A large number of professionals and students consume these smart drugs to enhance memory and focus.
    • Continuous product development using both natural and synthetic raw materials is further expected to propel market growth.
    • Furthermore, the surge in the vegan population in developed countries of Europe and North America is further expected to boost the need for plant-based nootropic products.
    • In addition, the surging demand for multi-utility drugs that work as energy boosters, antidepressants, and anxiety resistance further offer immense opportunities to product manufacturers.


    Want to have a closer look at this market report? Register Here

    Segment Analysis

    Distribution Channel Type

    Based on distribution channels, the nootropics market has been bifurcated into offline and online.

    • Among these, the online segment held a substantial market share in 2021 and is projected to register a robust CAGR of almost 14% during the review period.
    • This is mainly attributed to the growing preference for nootropics by students.
    • Easy payment platforms that fit into the regulatory standards of various countries have made payment operations easier.
    • Thus, key industry participants focus on online distribution channels to widen their customer base.

    Regional Insights

    By region, North America dominated the nootropics market in 2021 with an astounding share of around 40% and is projected to grow at a healthy CAGR during the review period.

    • This can be attributed to the presence of major healthcare companies, increasing consumer awareness about brain health, and changing lifestyles are expected to boost regional growth.
    • Around 50% of the adult population in the US consumes vitamin supplements, this is a key contribution to the regional nootropic industry.


    Want to know which region offers the best growth opportunities then, Register Here

    Critical Questions Answered in the Report

    • What are the key trends in the nootropics market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the nootropics market?
    • What are the key strategies adopted by the major vendors to lead in the nootropics market?
    • What is the market share of the top vendors?

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The market is segmented into the following categories.

    By Drug Type

    • Prescription Nootropics
    • OTC Nootropics

    By Application Type

    • Memory Enhancement
    • Mood & Depression
    • Attention & Focus
    • Longevity & Anti-aging
    • Sleep & Recovery
    • Anxiety

    By Distribution Channel Type

    • Online
    • Offline

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)


    Want to know the most attractive market segments? Register Here

    Key Players

    Key players operating in the nootropics market are-

    • Accelerated Intelligence Inc. (UK),
    • AlternaScript (The U.S),
    • HVMN (The U.S),
    • Onnit Labs, Inc. (The U.S),
    • Peak Nootropics (The U.S),
    • Teva Pharmaceutical Industries (Israel),
    • Purelife Bioscience Co., Ltd. (China),
    • United Pharmacies (Moldova), SupNootropic bio co.,ltd (The U.S), and
    • Powder City (The U.S).

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision-making for the existing players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Nootropics Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the drug types by distribution channel type.

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The nootropics market was estimated at USD 10.7 billion in 2021.

    The nootropics market is likely to reach USD 28.66 billion in 2028.

    The nootropics market is expected to witness an impressive growth of 15.07% CAGR during 2022-2028.

    Accelerated Intelligence Inc. (UK), AlternaScript (The U.S), HVMN (The U.S), Onnit Labs, Inc. (The U.S), Peak Nootropics (The U.S), Teva Pharmaceutical Industries (Israel), Purelife Bioscience Co., Ltd. (China), United Pharmacies (Moldova), SupNootropic bio co.,ltd (The U.S) and Powder City (The U.S) are among the key players in the market.

    North America dominated the nootropics market in 2021.

    Increasing demand for smart drugs and brain boosters, continuous product development using both natural and synthetic raw materials, and the surge in the vegan population in developed countries of Europe and North America are the factors driving the growth of the market.

    Nootropics companies, Pharmaceutical companies, Hospitals, Academic Institutions, Research Centers & Organizations are the target audience in the market.